INS and cardiovascular disorder: The sensitivity analysis excluding prevalent users of sulphonylureas at study entry showed increases in adjusted hazard ratios for all cause mortality and cardiovascular disease for insulin (see supplementary table 2: model E compared with model C) but similar hazard ratios for the other diabetes drug groups for all three outcomes.